Alert detail
FDA Approval: WELIREG (BELZUTIFAN) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA215383Specialty: OncologyAdded: 6/17/2026Effective: 2021-08-13federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.